| Authors: |
Mc Carthy L; Department of Neurology, VA Boston Healthcare System, Boston, MA, USA.; Department of Neurology, Mass General Brigham, Boston, MA, USA., Andersen BM; Department of Neurology, VA Boston Healthcare System, Boston, MA, USA.; Department of Neurology, Mass General Brigham, Boston, MA, USA., Wen PY; Center for Neuro-Oncology, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Reardon DA; Center for Neuro-Oncology, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Tobochnik S; Department of Neurology, VA Boston Healthcare System, Boston, MA, USA. Steven.Tobochnik@va.gov.; Center for Neuro-Oncology, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. Steven.Tobochnik@va.gov. |
